Wealth Plan Partners, LLC Seelos Therapeutics, Inc. Transaction History

Wealth Plan Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$0.16 - $1.64 $965 - $9,894	6,033 Added 11.95%	56,533 $10.4 Million
Q2 2023 Jul 31, 2023	SELL	$0.66 - $1.22 $15,307 - $28,295	-23,193 Reduced 31.47%	50,500 $60.3 Million
Q1 2023 May 10, 2023	SELL	$0.59 - $1.04 $2,832 - $4,992	-4,800 Reduced 6.12%	73,693 $50.9 Million
Q4 2022 Feb 16, 2023	BUY	$0.66 - $259.46 $16,693 - $6.56 Million	25,293 Added 47.54%	78,493 $55.1 Million
Q1 2022 May 03, 2022	BUY	$0.84 - $1.71 $840 - $1,710	1,000 Added 1.92%	53,200 $33,000
Q4 2021 Feb 01, 2022	BUY	$1.59 - $2.38 $7,950 - $11,900	5,000 Added 10.59%	52,200 $60,000
Q3 2021 Dec 09, 2021	BUY	$1.69 - $2.89 $20,618 - $35,258	12,200 Added 34.86%	47,200 $113,000
Q2 2021 Aug 19, 2021	BUY	$2.64 - $6.32 $39,600 - $94,800	15,000 Added 75.0%	35,000 $78,000
Q3 2019 Nov 15, 2019	BUY	$0.92 - $2.15 $9,200 - $21,500	10,000 Added 100.0%	20,000 $14,000
Q2 2019 Aug 19, 2019	BUY	$2.11 - $3.3 $21,100 - $33,000	10,000 New	10,000 $17,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $117M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Wealth Plan Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Plan Partners, LLC with notifications on news.